JPM26: Medtech CEO says conference’s appeal in decline
The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.
16 January 2026
16 January 2026
The limited time to ‘get things done’ and the high cost of attending the J.P. Morgan conference are factors that are beginning to dampen its appeal.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.